Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature

Table 3 Summary characteristics of studies included in the literature-based meta-analysis

Reference	Cohort	Country	Age, mean (SD) or median (25th–75th)	No. (%) males	N	No. incident events	Follow-up, years	Diabetes ascertainment
Bruneck study	Bruneck	Italy	Mean = 58 (11)	403 (50)	815	94	Median = 20.0	^b
Mora et al. [5]	WHS	US	Mean = 55 (7)	0 (0)	26,746	1670	Median = 13.3	^a
Kamstrup et al. [6]	CCHS and CGPS	Denmark	Median = 58 (47–67)	34,691 (45)	29,106	2157	Not provided	^a
Ye et al. [9]	EPIC-Norfolk	UK	Mean = 59 (9)	8248 (45)	17,908	593	Mean = 9.8	^a

CCHS Copenhagen City Heart Study, CGPS Copenhagen General Population Study, EPIC-Norfolk European Prospective Investigation of Cancer-Norfolk, WHS Women’s Health Study
^aSelf-report validated by linkage to other sources
^bAmerican Diabetes Association criteria and/or use of diabetes medication

ISSN: 1475-2840